Answers from the Lab

Feb 26 2025 343 ep. 13 mins 1.2k
Answers from the Lab Podcast artwork

A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.

  Health & Fitness  Science
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


The Impacts of STI Testing Innovation: Elitza Theel, Ph.D.

Feb 26 2025 14 mins  
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, for a conversation about innovation in testing for sexually transmitted infections (STI). Topics include: The advantages and challenges of new t

Why a Quality Management Program is Essential: Bill Morice, M.D., Ph.D.

Feb 12 2025 16 mins  
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, for a conversation about quality management. Specifically, they discuss: The benefit of investing in quality management for patients, staff, and the organizat

Importance of Monitoring Business Trends in Diagnostics: Bill Morice, M.D., Ph.D.

Jan 29 2025 18 mins  
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss recent business trends in diagnostics and why it is important for pathologists to stay informed about these trends. Their conversation covers: Wh

Assay identifies most known membranous nephropathy antigens: Sanjeev Sethi, M.D., Ph.D.

Jan 20 2025 19 mins  
Sanjeev Sethi, M.D., Ph.D., explains how Mayo Clinic Laboratories' new mass spectrometry test (Mayo ID: MSMN) identifies most antigens now known to cause membranous nephropathy. Precise identification of antigens is important for optimal management of this serious kidney disease.Speaker 3: (00:32) Would you mind telling us a little bit about yourself and your background? Speaker 3:

Innovations Set to Shape the Industry in 2025: Bill Morice, M.D., Ph.D.

Jan 15 2025 13 mins  
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss Dr. Morice’s recent article in Becker’s Hospital Review, “Nine Developments Predicted to Shape Laboratory Medicine and Diagnostics in 2025,

Benefits of Automation in the Laboratory: Erin Graf, Ph.D.

Jan 08 2025 12 mins  
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Erin Graf, Ph.D., co-director of Microbiology in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Arizona, to discuss benefits of automation in the laboratory. Topics of discussion include:Specific examples of how th

The Latest on H5 Avian Influenza: Bill Morice, M.D., Ph.D.

Jan 01 2025 9 mins  
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss emerging concerns about H5N1 avian influenza. Specific topics of discussion include:Patterns of transmission and what they indicate about the poten

The Rapid Evolution of Artificial Intelligence: Bill Morice, M.D., Ph.D.

Dec 11 2024 15 mins  
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the progress of artificial intelligence (AI) and what’s next in this space.Specific topics of discussion include:What’s driving the rapid accel

Global Vigilance in Preventing Infectious Disease Outbreaks: Bill Morice, M.D., Ph.D.

Dec 04 2024 11 mins  
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the latest in infectious disease outbreaks. Specific topics of discussion include:Recent trends in the spread of H5 bird flu and dengue fever. Why

Expanding Lab Access to Improve Health Equity: Bill Morice, M.D., Ph.D.

Nov 20 2024 15 mins  
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss how labs can enhance patient access to improve health equity.Specific topics of discussion include:Innovations creating new possibilities, such as